All Stories

  1. Penicillin-resistant Streptococcus dysgalactiae subsp. equisimilis and the association with penicillin-binding protein mutations: a population genotypic and p...
  2. Artificial intelligence automation of urine culture reading with BD Kiestra Urine Culture Application: measurement of performance and potential efficiency gains
  3. Australian contribution to the history of amoebic meningitis and encephalitis
  4. Genomic interrogation of invasive group A Streptococcus (iGAS) epidemiology and COVID-19 impacts in Victoria, Australia: a 6-year retrospective study
  5. Burkholderia cenocepacia outbreak linked to taps in a neonatal intensive care unit
  6. Is neutrophil to lymphocyte ratio an accurate predictor of neonatal sepsis in premature infants?
  7. Identifying Gaps in the International Consensus Case Definitions for Invasive Aspergillosis: A Review of Clinical Cases Not Meeting These Definitions
  8. Use of echinocandin outpatient parenteral antimicrobial therapy for the treatment of infection caused by Candida spp.: utilization, outcomes and impact of a change to weekly dosing
  9. HIV treatment outcomes after 10 years on ART in the TREAT Asia Observational Database (TAHOD) and Australian HIV Observational Database (AHOD)
  10. ATAGI Targeted Review 2023: Vaccination for prevention of influenza in Australia
  11. Treatment‐resistant tinea caused by Trichophyton indotineae in Australia
  12. Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial
  13. Defining the phylogenetics and resistome of the major Clostridioides difficile ribotypes circulating in Australia
  14. Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines—an exploratory sub-study of the BRACE trial
  15. Pathogenomic analysis and characterization of Pasteurella multocida strains recovered from human infections
  16. Antimicrobial surveillance: A 20-year history of the SMART approach to addressing global antimicrobial resistance into the future
  17. Correction: Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000–2012)
  18. Cryptococcal laryngitis in an immunocompetent asthmatic patient using inhaled corticosteroids
  19. Utility of Proximal Bone Cultures in Diabetes-related Foot Infections
  20. Comparison of contemporary invasive and non-invasive Streptococcus pneumoniae isolates reveals new insights into circulating anti-microbial resistance determinants
  21. Nocardia species distribution and antimicrobial susceptibility within Australia
  22. Invasive aspergillosis in adult patients in Australia and New Zealand: 2017–2020
  23. Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial
  24. Current Epidemiology and Clinical Features of Cryptococcus Infection in Patients Without Human Immunodeficiency Virus: A Multicenter Study in 46 Hospitals in Australia and New Zealand
  25. Clostridioides difficileInfection: Clinical Practice and Health Outcomes in 6 Large Tertiary Hospitals in Eastern Australia
  26. A rise in invasive and non‐invasive group A streptococcal disease case numbers in Melbourne in late 2022
  27. A simplified, amplicon-based method for whole genome sequencing of human respiratory syncytial viruses
  28. Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000–2012)
  29. Long term antibiotic prescribing in the community: 6 years of Australian national data
  30. Impact of Kiestra total laboratory automation workflow on job satisfaction, education and quality: a staff survey
  31. New diagnosis of HIV with Cryptococcus neoformans infection presenting as a pleural syndrome
  32. Trichomoniasis among men presenting to a sexual health clinic in Melbourne, Australia
  33. Multi-site implementation of whole genome sequencing for hospital infection control: A prospective genomic epidemiological analysis
  34. Acute Tubular Necrosis and Thrombocytopenia Associated With Rifampin Use: Case Report and Review
  35. Outcomes in Medicare‐ineligible people living with human immunodeficiency virus in a large healthcare network in Melbourne 2004–2019
  36. Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2019: the Influenza Complications Alert Network FluCAN
  37. Victorian Specialist Immunisation Services (VicSIS) – bolstering adult clinics for COVID-19 vaccines
  38. Reductions in Antibiotic Prescribing in Australia During the SARS-CoV-2 Pandemic: National Prescribing Data
  39. Genomic characterisation of CC398 MRSA causing severe disease in Australia
  40. Corynebacterium macginleyi in the era of MALDI-TOF MS: epidemiology, susceptibility patterns and prevalence of co-infection
  41. Long-Term Outcomes in Patients on Life-Long Antibiotics: A Five-Year Cohort Study
  42. Under-utilisation of cardioprotective glucose-lowering medication in diabetics living with HIV
  43. Surveillance for severe influenza and COVID-19 in patients admitted to sentinel Australian hospitals in 2020: the Influenza Complications Alert Network (FluCAN)
  44. Off‐target effects of bacillus Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2: implications for protection against severe COVID‐19
  45. BCG vaccination to reduce the impact of COVID-19 in healthcare workers: Protocol for a randomised controlled trial (BRACE trial)
  46. Coronavirus testing in women attending antenatal care
  47. Molecular characterization of fosfomycin-resistant Escherichia coli urinary tract infection isolates from Australia
  48. Moving beyond “Red Man Syndrome”
  49. Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015–18
  50. Infective Endocarditis in Patients on Chronic Hemodialysis
  51. Clinical illness with viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) virus presenting 72 days after infection in an immunocompromised patient
  52. Early Outpatient Treatment of SARS-CoV-2 (COVID-19): A Comment
  53. Favipiravir and the Need for Early Ambulatory Treatment of COVID-19
  54. Increased diagnostic yield of routine multiplex PCR compared to clinician requested testing for detection of Trichomonas vaginalis
  55. COVID‐19 in Australia: our national response to the first cases of SARS‐CoV‐2 infection during the early biocontainment phase
  56. Etymologia: Buruli Ulcer
  57. Pilot study of a combined genomic and epidemiologic surveillance program for hospital-acquired multidrug-resistant pathogens across multiple hospital networks in Australia
  58. Laboratory-Based Surveillance of Clostridium difficile Infection in Australian Health Care and Community Settings, 2013 to 2018
  59. Case Report: Japanese Encephalitis Associated with Chorioretinitis after Short-Term Travel to Bali, Indonesia
  60. Identification and characterisation of fosfomycin resistance in Escherichia coli urinary tract infection isolates from Australia
  61. Viral Genomics to Inform Infection-control Response in Occupational Coronavirus Disease 2019 (COVID-19) Transmission
  62. RE: “EARLY OUTPATIENT TREATMENT OF SYMPTOMATIC, HIGH-RISK COVID-19 PATIENTS THAT SHOULD BE RAMPED UP IMMEDIATELY AS KEY TO THE PANDEMIC CRISIS”
  63. Rapid Gel Card Agglutination Assays for Serological Analysis Following SARS-CoV-2 Infection in Humans
  64. Clinical evaluation of AusDiagnostics SARS-CoV-2 multiplex tandem PCR assay
  65. Isolation and rapid sharing of the 2019 novel coronavirus ( SARS ‐CoV‐2) from the first patient diagnosed with COVID ‐19 in Australia
  66. The burden of infective endocarditis in an Australian cohort of people who inject drugs
  67. Intermittent negative blood cultures in Staphylococcus aureus bacteremia; A retrospective study of 1071 episodes
  68. Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2018: the Influenza Complications Alert Network (FluCAN)
  69. Should we routinely test for Mycoplasma genitalium when testing for other sexually transmitted infections?
  70. Surveillance of life-long antibiotics—A cross-sectional cohort study assessing patient attitudes and understanding of long-term antibiotic consumption
  71. HIV presenting as AIDS in previously undiagnosed tourists in a low-prevalence setting
  72. Review of HIV testing recommendations in Australian specialty guidelines for HIV indicator conditions: a missed opportunity for recommending testing?
  73. Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2017: the Influenza Complications Alert Network (FluCAN)
  74. Genomic interrogation of the burden and transmission of multidrug-resistant pathogens within and across hospital networks
  75. Management of gonorrhoea in a hospital network: are we following best practice?
  76. Response to letter to editor regarding Lin et al ‘Prevalence of HIV indicator conditions in late presenting patients with HIV: a missed opportunity for diagnosis?’
  77. Anti-Helicobacter pylori activity of ethoxzolamide
  78. Identification and diversity of Actinomyces species in a clinical microbiology laboratory in the MALDI-TOF MS era
  79. Prevalence of HIV indicator conditions in late presenting patients with HIV: a missed opportunity for diagnosis?
  80. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance
  81. Global spread of three multidrug-resistant lineages of Staphylococcus epidermidis
  82. Influenza Epidemiology, Vaccine Coverage and Vaccine Effectiveness in Children Admitted to Sentinel Australian Hospitals in 2017: Results from the PAEDS-FluCAN Collaboration
  83. Increasing tolerance of hospital Enterococcus faecium to handwash alcohols
  84. Foreign tick smuggling rickettsia evades Australian border control
  85. Respiratory virus detection and co-infection in children and adults in a large Australian hospital in 2009-2015
  86. Life-long antimicrobial therapy: where is the evidence?
  87. C-reactive protein and immature-to-total neutrophil ratio have no utility in guiding lumbar puncture in suspected neonatal sepsis
  88. Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia
  89. Underdiagnosis of Chlamydia trachomatis and Chlamydia psittaci revealed by introduction of respiratory multiplex PCR assay with Chlamydiaceae family primers
  90. Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27
  91. Myocarditis Caused by Human Parechovirus in Adult
  92. Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the Internati...
  93. Herpes simplex virus-2 transmission following solid organ transplantation: Donor-derived infection and transplantation from prior organ recipients
  94. Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma
  95. Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study
  96. Teicoplanin non-susceptible coagulase-negative staphylococci in a large Australian healthcare network: Implications for treatment with vancomycin
  97. Management of dengue in Australian travellers: a retrospective multicentre analysis
  98. Repeated Vaccination Does Not Appear to Impact Upon Influenza Vaccine Effectiveness Against Hospitalization With Confirmed Influenza
  99. The impact of changes in HIV management guidelines on time to treatment initiation in Australia
  100. Changing epidemiology of candidaemia in Australia
  101. Integrase-resistant HIV in an antiretroviral-naive patient in Australia
  102. Surveillance of life-long antibiotics: a review of antibiotic prescribing practices in an Australian Healthcare Network
  103. Polyclonal emergence ofvanAvancomycin-resistantEnterococcus faeciumin Australia
  104. Changing epidemiology of candidaemia in Australia
  105. Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008–14: results from the Study for Monitoring Antimicrobial Resistance...
  106. Bacteroides pyogenes causing serious human wound infection from animal bites
  107. Epidemiology and Mortality of Staphylococcus aureus Bacteremia in Australian and New Zealand Children
  108. Improved standardization and potential for shortened time to results with BD Kiestra™ total laboratory automation of early urine cultures: A prospective comparison with manual processing
  109. Cryptococcemia in primary HIV infection
  110. Increasing tolerance of hospital Enterococcus faecium to hand-wash alcohols
  111. Validated Risk Score for Predicting 6‐Month Mortality in Infective Endocarditis
  112. Australasian Society of Infectious Diseases updated guidelines for the management ofClostridium difficileinfection in adults and children in Australia and New Zealand
  113. Different faces of Nocardia infection in renal transplant recipients
  114. Mucormycosis in Australia: contemporary epidemiology and outcomes
  115. Combination Therapy Did Not Reduce 30-Day Treatment Failure in Patients With Staphylococcus aureus Bacteremia (SAB)
  116. Prediction Model to Identify Patients at Risk of 30-Day Treatment Failure in Patients With Staphylococcus aureus Bacteremia
  117. Influenza vaccine effectiveness against hospitalisation with influenza in adults in Australia in 2014
  118. Low rates of endocarditis in healthcare-associated Staphylococcus aureus bacteremia suggest that echocardiography might not always be required
  119. Outbreak of vanB vancomycin-resistant Enterococcus faecium colonization in a neonatal service
  120. Disseminated Enteroviral Infection Associated with Obinutuzumab
  121. A history of infection with varicella is strongly predictive of the presence of varicella-zoster virus antibodies in a heterogenous Australian HIV cohort
  122. Antiretroviral treatment use, co-morbidities and clinical outcomes among Aboriginal participants in the Australian HIV Observational Database (AHOD)
  123. Acute HIV infection presenting as erythema multiforme in a 45-year-old heterosexual man
  124. Molecular characterization and antimicrobial susceptibilities of Clostridium difficile clinical isolates from Victoria, Australia
  125. Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile , 2013–14
  126. Human Wound Infection with Mannheimia glucosida following Lamb Bite
  127. Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality
  128. Correction: Geographical Variability in the Likelihood of Bloodstream Infections Due to Gram-Negative Bacteria: Correlation with Proximity to the Equator and Health Care Expenditure
  129. Local acquisition and nosocomial transmission of Klebsiella pneumoniae harbouring the blaNDM-1 gene in Australia
  130. Emergence and spread of predominantly community-onset Clostridium difficile PCR ribotype 244 infection in Australia, 2010 to 2012
  131. Diagnosis and Management of Clostridium difficile Infection
  132. Candida Infective Endocarditis: an Observational Cohort Study with a Focus on Therapy
  133. Vancomycin vintage: my favourite DRESS
  134. Association Between Surgical Indications, Operative Risk, and Clinical Outcome in Infective Endocarditis
  135. Mycobacterium haemophilumbone and joint infection in HIV/AIDS: case report and literature review
  136. Who really knows their patients' penicillin adverse drug reaction status? A cross-sectional survey
  137. One-year outcome following biological or mechanical valve replacement for infective endocarditis
  138. Geographical Variability in the Likelihood of Bloodstream Infections Due to Gram-Negative Bacteria: Correlation with Proximity to the Equator and Health Care Expenditure
  139. Clinical and Microbiological Characteristics of Eggerthella lenta Bacteremia
  140. Acanthamoeba Encephalitis: Isolation of Genotype T1 in Mycobacterial Liquid Culture Medium
  141. Comparing the identification of Clostridium spp. by two Matrix-Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) mass spectrometry platforms to 16S rRNA PCR sequencing as a reference standard: A detailed analysis of age of culture and sam...
  142. HIV and aging: insights from the Asia Pacific HIV Observational Database (APHOD)
  143. Impact of Early Valve Surgery on Outcome of Staphylococcus aureus Prosthetic Valve Infective Endocarditis: Analysis in the International Collaboration of Endocarditis–Prospective Cohort Study
  144. Rapid Time to Results and High Sensitivity of the CarbaNP Test on Early Cultures
  145. Genetic and Molecular Predictors of High Vancomycin MIC in Staphylococcus aureus Bacteremia Isolates
  146. Emergence of a Ribotype 244 Strain of Clostridium difficile Associated With Severe Disease and Related to the Epidemic Ribotype 027 Strain
  147. Eggerthella lenta Bacteremia Complicated by Spondylodiscitis, Psoas Abscess, and Meningitis
  148. Comparing the identification of clostridium SPP. from blood culture using phenotypic, molecular, and two matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry methods: a detailed analysis including the impact of cultu...
  149. Novel use of toxigenic gene analysis for the identification of clostridium species
  150. Vancomycin-resistant enterococci colonization does not increase mortality in end-stage kidney failure: a case–control study
  151. Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemia
  152. Hampered by historical paradigms - echinocandins and the treatment ofCandidaendocarditis
  153. Streptococcus pyogenes aortic aneurysm infection: forgotten but not gone
  154. Exacerbation phenotyping in chronic obstructive pulmonary disease
  155. Influenza Vaccine Effectiveness against Hospitalisation with Confirmed Influenza in the 2010–11 Seasons: A Test-negative Observational Study
  156. Peripheral intravenous catheter-associated Staphylococcus aureus bacteraemia: more than 5 years of prospective data from two tertiary health services
  157. Antifungal Therapy and Management of Complications of Cryptococcosis due to Cryptococcus gattii
  158. HACEK Infective Endocarditis: Characteristics and Outcomes from a Large, Multi-National Cohort
  159. “Down the drain”: carbapenem-resistant bacteria in intensive care unit patients and handwashing sinks
  160. Vancomycin AUC/MIC Ratio and 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia
  161. Influence of the Timing of Cardiac Surgery on the Outcome of Patients With Infective Endocarditis and Stroke
  162. Successful use of eltrombopag without splenectomy in refractory HIV-related immune reconstitution thrombocytopenia
  163. Clinical Manifestations of Cryptococcus gattii Infection: Determinants of Neurological Sequelae and Death
  164. New HIV diagnosis after occupational exposure screening: the importance of reporting needlestick injuries
  165. Prevalence of antimicrobial-resistant organisms in residential aged care facilities
  166. Contamination of renal patients hospital chart covers with vancomycin resistant enterococci: Handle!with care
  167. The Dominant Australian Community-Acquired Methicillin-Resistant Staphylococcus aureus Clone ST93-IV [2B] Is Highly Virulent and Genetically Distinct
  168. Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: A test-negative case control study
  169. Rat bite fever as a presenting illness in a patient with AIDS
  170. Methicillin-Susceptible Staphylococcus aureus Endocarditis Isolates Are Associated With Clonal Complex 30 Genotype and a Distinct Repertoire of Enterotoxins and Adhesins
  171. Clostridium difficile laboratory testing in Australia and New Zealand: national survey results and Australasian Society for Infectious Diseases recommendations for best practice
  172. Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations
  173. Curtobacterium flaccumfaciens Septic Arthritis following Puncture with a Coxspur Hawthorn Thorn
  174. Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality
  175. Refractory Bartonella quintana bacillary angiomatosis following chemotherapy for chronic lymphocytic leukaemia
  176. Novel Use of Tryptose Sulfite Cycloserine Egg Yolk Agar for Isolation of Clostridium perfringens during an Outbreak of Necrotizing Enterocolitis in a Neonatal Unit
  177. Autoimmune haemolytic anaemia: an unusual presentation of HIV seroconversion disease
  178. Neurocysticercosis Causing Sudden Death
  179. MELTING MUSCLES
  180. Heterogeneous Vancomycin‐Intermediate Susceptibility Phenotype in Bloodstream Methicillin‐Resistant Staphylococcus aureus Isolates from an International Cohort of Patients with Infective Endocarditis: Prevalence, Genotype, and Clinical Significance
  181. Quadrivalent Human Papillomavirus recombinant vaccine associated lipoatrophy
  182. Determinants of mortality in non-neutropenic ICU patients with candidaemia
  183. Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection
  184. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management
  185. Increasing rates and clinical consequences of nalidixic acid-resistant isolates causing enteric fever in returned travellers: an 18-year experience
  186. Primary psoas muscle abscess in pregnancy
  187. SMART‐COP: A Tool for Predicting the Need for Intensive Respiratory or Vasopressor Support in Community‐Acquired Pneumonia
  188. Report of oral clarithromycin desensitization
  189. Phylogenetic Analysis of Viridans Group Streptococci Causing Endocarditis
  190. The Etiology of Community‐Acquired Pneumonia in Australia: Why Penicillin plus Doxycycline or a Macrolide Is the Most Appropriate Therapy
  191. Genotypic Diversity of Coagulase-Negative Staphylococci Causing Endocarditis: a Global Perspective
  192. Constructing clinical indicators for multiresistant organisms. Where do we begin?
  193. Investigation of an outbreak of Serratia marcescens in a neonatal unit via a case-control study and molecular typing
  194. Molecular Typing of AustralianScedosporiumIsolates Showing Genetic Variability and NumerousS. aurantiacum
  195. Disinfection of Burkholderia cepacia complex from non-touch taps in a neonatal nursery
  196. Unrecognised vitamin D deficiency: low concentrations in African migrants with HIV in Australia
  197. What's hanging around your neck? Pathogenic bacteria on identity badges and lanyards
  198. Non-HACEK Gram-Negative Bacillus Endocarditis
  199. A longitudinal study of Acinetobacter in three Australian hospitals
  200. Corynebacterium kutscheri Infection of Skin and Soft Tissue following Rat Bite
  201. Risk factors for peritoneal dialysis-related peritonitis: Can we reduce the incidence and improve patient selection?
  202. Continuous-infusion penicillin home-based therapy for serious infections due to penicillin-susceptible pathogens
  203. Acute pancreatitis caused by tipranavir/ritonavir-induced hypertriglyceridaemia
  204. Rat-bite fever septic arthritis: illustrative case and literature review
  205. Active Surveillance of Candidemia, Australia
  206. Duration of In Vivo Antimicrobial Activity of Antibiotic-impregnated Cerebrospinal Fluid Catheters
  207. Infectious complications of traditional Samoan tattooing
  208. The microbiology and outcome of sepsis in Victoria, Australia
  209. Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database
  210. Eosinophilic folliculitis
  211. Lichenoid drug eruption to tenofovir in an HIV/hepatitis B virus co-infected patient
  212. Fatal Case of Toxic Shock-Like Syndrome Due to Group C Streptococcus Associated with Superantigen Exotoxin
  213. Impact of an electronic antibiotic advice and approval system on antibiotic prescribing in an Australian teaching hospital
  214. Treatment Outcomes for Serious Infections Caused by Methicillin‐Resistant Staphylococcus aureus with Reduced Vancomycin Susceptibility
  215. Sequential cutaneous drug reactions to protease inhibitors in the context of occupational post-exposure prophylaxis
  216. Management of Aspergillus Osteomyelitis: Report of Failure of Liposomal Amphotericin B and Response to Voriconazole in an Immunocompetent Host and Literature Review
  217. Bacteraemia due to Stenotrophomonas maltophilia: An Analysis of 45 Episodes
  218. The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis
  219. FatalLegionella longbeachae infection following heart transplantation
  220. Polymicrobial septicaemia with Pseudomonas aeruginosa and Streptococcus pyogenes following traditional tattooing
  221. Acute hepatitis associated withCampylobacter jejuni bacteraemia
  222. The 1-month outcome of patients with a low probability Technegas ventilation/perfusion lung scan